Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors
US10004733B2 · kind B2 · utility
0Cited by
30References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 9, 2016 |
| Grant date | Jun 26, 2018 |
| Priority date | — |
| Expiry date | Feb 9, 2036 |
Classification
- Technology area (CPC —)General
Abstract
The invention relates to new pyridopyrazine derivative compounds of formula (I-A) or formula (I-B): to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.